No Data
No Data
Stifel Maintains Align Technology(ALGN.US) With Buy Rating, Maintains Target Price $275
Short Bets Against S&P 500 Healthcare Stock Rises in Feb; MRNA Stays Top Shorted
Dentsply, ZimVie Cut to Hold at Needham on Near-term Headwinds in the Dental Market
Dental Players Dentsply Sirona, ZimVie Show Weak Growth Outlook: Analyst
Align ENT + Allergy Partners With Princeton Allergy & Asthma Associates
ALGN Stock to Benefit From the Launch of Align X-ray Insights Solution